Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic
Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the development of life-threatening COVID-19 are believed to disproportionately affect certain at-risk populations. However, it is not clear whether individuals with cystic fibrosis (CF) are at a higher ri...
Main Authors: | Hannah R. Mathew, May Y. Choi, Michael D. Parkins, Marvin J. Fritzler |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Pulmonary Medicine |
Online Access: | https://doi.org/10.1186/s12890-021-01528-0 |
Similar Items
-
COVID-19: the novel SARS-CoV-2 pandemic
by: Roberto Alfonso Accinelli, et al.
Published: (2020-04-01) -
Systematic SARS-CoV-2 screening in cerebrospinal fluid during the COVID-19 pandemic
by: Grégory Destras, et al.
Published: (2020-08-01) -
Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures
by: Silke van Koningsbruggen-Rietschel, et al.
Published: (2021-08-01) -
SARS-CoV2, the COVID-19 Pandemic and Community Perceptions
by: Nikki Keene Woods, et al.
Published: (2021-02-01) -
An overview of SARS-COV-2 (COVID-19) disease pandemic
by: Sagorika Rai, et al.
Published: (2020-08-01)